Microbes, collectively, include bacteria, viruses, fungi, and parasites. For the past 70 years, antimicrobial drugs, such as antibiotics, have been successfully used to treat patients with bacterial and infectious diseases. Over time, however, many infectious organisms have adapted to the drugs designed to kill them, making the products less effective. To address this growing problem, NIAID is funding and conducting research on many aspects of antimicrobial (drug) resistance, including basic research on how microbes develop resistance, new and faster diagnostics, and clinical trials designed to find new vaccines and treatments effective against drug-resistant microbes.
New NIH Awards Will Support Development of Therapeutic Alternatives to Traditional Antibiotics—Jan. 11, 2016
NIH-Backed Vaccine Shows Promise Against Common Healthcare-Associated Infections—June 19, 2015
Multiple NIAID Efforts Investigating Vaccines, New Treatments for Gonorrhea—June 19, 2015
NIAID-Funded Scientists Developing New Antibiotic to Fight Resistant Infections—June 16, 2015
All Antimicrobial (Drug) Resistance News Releases
News From NIAID-Supported Institutions
Last Updated March 14, 2016